Lasa Supergenerics profitability ratios
Per cent unless marked ×
| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
Returns | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |||||
|---|---|---|---|---|---|---|
| −51.1% | −51.1% | −16.4% | −20.2% | −32.7% | ||
| −40.6% | −40.6% | −11.7% | −13.8% | −23.6% | ||
| −51.4% | −51.4% | −6.5% | −7.6% | −16.5% | ||
| −24.9% | −57.4% | −5.3% | −7.2% | −15.5% | ||
Margins | ||||||
| −137.2% | −113.0% | 4.4% | 2.1% | −5.1% | ||
| −136.9% | −136.9% | −4.2% | −8.2% | −15.5% | ||
| — | 24.2% | 6.5% | −45.6% | — | ||
| −244.5% | −137.7% | −13.6% | −18.3% | −32.6% | ||
| −260.4% | −135.6% | −10.4% | −20.8% | −29.8% | ||
| −90.8% | −90.8% | −2.0% | 1.4% | −29.6% | ||
Additional | ||||||
| −6.5% | 1.5% | 23.9% | −13.7% | 8.7% | ||
| −51.1% | −51.1% | −16.4% | −20.2% | −32.7% | ||
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.